• Mashup Score: 1
    Interview with Dr. Nadine Palermo and Dr. Ole-Petter Hamnvik - 26 day(s) ago

    NEJM Group’s Dr. André Sofair checks in with the two endocrinologists who will guide our ADA meeting coverage this year: Dr. Nadine Palermo and Dr. Ole-Petter Hamnvik.

    Source: cdn.jwplayer.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of JWatch
      JWatch

      NEJM Group’s Dr. André Sofair checks in with the two endocrinologists who will guide our #ADASciSessions coverage this year: Dr. Nadine Palermo and Dr. Ole-Petter Hamnvik. Watch what themes and topics have caught their attention: https://t.co/lt6mjrfLd6 @PalermoNadine3 https://t.co/atCvCmWn6B

  • Mashup Score: 3
    Interview with Dr. Komal Jhaveri - 1 month(s) ago

    NEJM Group’s Dr. Inas Abuali talks with Dr. Komal Jhaveri about the results from the INAVO120 trial.

    Source: cdn.jwplayer.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of JWatch
      JWatch

      Dr. Inas Abuali talks with Dr. Komal Jhaveri about the INAVO120 trial, which showed better overall survival when inavolisib was added to palbociclib–fulvestrant in patients with PIK3CA-mutated advanced breast cancer. https://t.co/QpAPjD4kHZ @inas_md #ASCO25 #bcsm @jhaveri_komal https://t.co/l5iG1a7T8P

  • Mashup Score: 5
    A Final Chat with Our Clinician-Guides for AAN 2025 - 3 month(s) ago

    Dr. Ali Raja checks in with Dr. Teshamae Monteith and Dr. Seemant Chaturvedi to find out what their biggest takeaways from AAN 2025 were.

    Source: cdn.jwplayer.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of JWatch
      JWatch

      NEJM Group's @AliRaja_MD checks in with Dr. Teshamae Monteith and Dr. Seemant Chaturvedi to find out their biggest clinical takeaways from the American Academy of Neurology's annual meeting. https://t.co/h5jGYoUpk2 #AANAM @headacheMD @ChaturvediNeuro https://t.co/m8VKqxqxhf

  • Mashup Score: 1
    Interview with Dr. Robert Fox - 3 month(s) ago

    NEJM Group’s Dr. Ali Raja talks with Dr. Robert Fox about the results of his group’s phase 3 study on tolebrutinib in nonrelapsing secondary progressive multiple sclerosis.

    Source: cdn.jwplayer.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of JWatch
      JWatch

      NEJM Group’s @AliRaja_MD talks with Dr. Robert Fox about the results of a phase 3 study on tolebrutinib in nonrelapsing secondary progressive multiple sclerosis. https://t.co/XJtlcfD8to #AANAM https://t.co/2QGsAwFrdR

  • Mashup Score: 11
    Interview with Dr. Teshamae Monteith and Dr. Seemant Chaturvedi - 3 month(s) ago

    Dr. Teshamae Monteith and Dr. Seemant Chaturvedi, our clinician-guides for the AAN 2025 Annual Meeting, talk to NEJM Group’s Dr. Ali Raja about what abstracts they’re most excited about, including…

    Source: cdn.jwplayer.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of JWatch
      JWatch

      The American Academy of Neurology's annual meeting begins this weekend. @headacheMD and @ChaturvediNeuro talk with Dr. Ali Raja about what studies they’re most excited about, covering headaches, MS, Alzheimer’s disease, and health equity. https://t.co/XCgTON7PXn #AANAM https://t.co/ZHnS6L2vgb

Load More